title: Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.
abstract: Hepatitis B reactivation due to chemotherapy is a cause of serious morbidity and mortality in some of the patients with cancer. In this study, we retrospectively assessed the prevalence of hepatitis B reactivation among the patients undergoing cytotoxic chemotherapy. We investigated efficacy of lamivudine prophylaxis against hepatitis B reactivation as well.
authors.affiliation: Department of Internal Medicine, Division of Medical Oncology, Selcuk University Meram Medical Faculty, Konya, Turkey. droneren@hotmail.com
authors.forename: Orhan Onder
authors.initials: OO
authors.lastname: Eren
authors.forename: Mehmet
authors.initials: M
authors.lastname: Artac
authors.forename: Melih Cem
authors.initials: MC
authors.lastname: Boruban
authors.forename: Ozlem
authors.initials: O
authors.lastname: Yavas
authors.forename: Ugur
authors.initials: U
authors.lastname: Arslan
authors.forename: Metin
authors.initials: M
authors.lastname: Basaranoglu
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000378:metabolism*; D006515:Hepatitis B virus / Q000187:drug effects / Q000254:growth & development*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000821:virology*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D006514:Hepatitis B Surface Antigens; D019259:Lamivudine